Company / Debt per Share
Biogen Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$43.39
FY2025
5-year range
$36.02 / $47.20
FY2021-FY2025
Trend
-0.8%
vs FY2024
Sector context
#6 of 85
Health Care
What the data says
Among 85 Health Care companies, Biogen is in the bottom 7% for debt per share. Debt per Share has fluctuated over the past 10 years, ranging from $21.08 in FY2019 to $47.20 in FY2023.
Based on SEC 10-K filings.
43.39 in FY2025 with a 5-year CAGR of +2.9%. Top quartile in the Health Care sector.
Improved from $47.20 to $43.39 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- +1.7%
- 5-Year CAGR
- +2.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 85This company $43.39 Sector average $122.37
▼
-64.5% below sector average
Key checks
Key Insights
- In FY2025, debt per share decreased 0.8% year-over-year.
- Ranks #6 out of 85 companies in the Health Care sector.
- Peak debt per share was recorded in FY2023.
- Lowest debt per share in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $43.39 | -0.8% |
| FY2024 | $43.72 | -7.4% |
| FY2023 | $47.20 | +14.5% |
| FY2022 | $41.21 | +14.4% |
| FY2021 | $36.02 | -4.4% |
| FY2020 | $37.66 | +78.6% |
| FY2019 | $21.08 | -23.3% |
| FY2018 | $27.50 | +0.0% |
| FY2017 | $27.49 | -7.7% |
| FY2016 | $29.79 | +7.2% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026